chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: asthma, bronchitis; bronchitis; nausea; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of ASTHMA (asthma, bronchitis), BRONCHITIS (bronchitis), VACCINATION SITE PAIN (pain at injection site) and NAUSEA (nausea) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006MZ0A) for COVID-19 vaccination.     The patient's past medical history included Polycythemia (Polycythemia vera blood disorder). Concomitant products included HYDROXYUREA and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 14-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Feb-2021, the patient experienced VACCINATION SITE PAIN (pain at injection site). On 04-Mar-2021, the patient experienced ASTHMA (asthma, bronchitis), BRONCHITIS (bronchitis) and NAUSEA (nausea). The patient was treated with AZITHROMYCIN (Z-PAK) at an unspecified dose and frequency and LEVOFLOXACIN (LEVAQUIN) at an unspecified dose and frequency. At the time of the report, ASTHMA (asthma, bronchitis), BRONCHITIS (bronchitis), VACCINATION SITE PAIN (pain at injection site) and NAUSEA (nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Chest X-ray: clear (normal) clear. On an unknown date, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment for the events also included an unspecified rescue inhaler and steroid.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Rash pruritic
Clinical narrative: Angry itching rash on the side of his stomach; Red; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH PRURITIC (Angry itching rash on the side of his stomach) and ERYTHEMA (Red) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013AZ1A) for COVID-19 vaccination.     The patient's past medical history included Eczema and Liver transplant (The patient is a liver transplant recipient since 12 Oct 2009.) on 12-Oct-2009. Concurrent medical conditions included Blood pressure (High blood pressure was reported.). Concomitant products included LOSARTAN for Blood pressure high, TACROLIMUS, AMLODIPINE, PRAVASTATIN, ACETYLSALICYLIC ACID (BABY ASPIRIN), ACICLOVIR SODIUM (ACYCLOVIR ABBOTT VIAL) and FISH OIL (FISH OIL OMEGA 3) for an unknown indication.    On 04-Mar-2021 at 3:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced RASH PRURITIC (Angry itching rash on the side of his stomach) and ERYTHEMA (Red). The patient was treated with CLOBETASOL PROPIONATE (CLOBETASOL 0.05%) for Itchy rash, at a dose of UNK dosage form. At the time of the report, RASH PRURITIC (Angry itching rash on the side of his stomach) and ERYTHEMA (Red) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The reporter states that at his routine appointment with his liver doctor, he showed rash to the doctor and the doctor told him that it was normal.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Chills, Nausea, Pyrexia
Clinical narrative: Fever; Nausea; Chills; Chest pain; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain), PYREXIA (Fever), NAUSEA (Nausea) and CHILLS (Chills) in a 30-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced CHEST PAIN (Chest pain). On an unknown date, the patient experienced PYREXIA (Fever), NAUSEA (Nausea) and CHILLS (Chills). At the time of the report, CHEST PAIN (Chest pain), PYREXIA (Fever), NAUSEA (Nausea) and CHILLS (Chills) outcome was unknown.            Concomitant medication was not provided.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue
Clinical narrative: barely had energy to walk out of the restaurant,wasn't active for her age; fatigue,tired; no energy; This spontaneous case was reported by a pharmacist and describes the occurrence of ASTHENIA (no energy), ASTHENIA (barely had energy to walk out of the restaurant,wasn't active for her age) and FATIGUE (fatigue,tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced ASTHENIA (no energy) and FATIGUE (fatigue,tired). On 11-Mar-2021, the patient experienced ASTHENIA (barely had energy to walk out of the restaurant,wasn't active for her age). At the time of the report, ASTHENIA (no energy), ASTHENIA (barely had energy to walk out of the restaurant,wasn't active for her age) and FATIGUE (fatigue,tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported.  No Treatments were reported.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Rash on Stomach; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash on Stomach) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced RASH (Rash on Stomach). The patient was treated with FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for Rash, at a dose of UNK dosage form. At the time of the report, RASH (Rash on Stomach) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Hypersensitivity, Injection site pain, Musculoskeletal stiffness, Neck pain
Clinical narrative: pain from injection site towards up to the neck; bad irritation; Ear was aching; Felt like crook in the neck; pain from injection site towards up to the neck,When she would touch the injection site and it was still sore; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NECK PAIN (pain from injection site towards up to the neck), HYPERSENSITIVITY (bad irritation), EAR PAIN (Ear was aching), MUSCULOSKELETAL STIFFNESS (Felt like crook in the neck) and INJECTION SITE PAIN (pain from injection site towards up to the neck,When she would touch the injection site and it was still sore) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 00TM20A) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced NECK PAIN (pain from injection site towards up to the neck), HYPERSENSITIVITY (bad irritation), EAR PAIN (Ear was aching), MUSCULOSKELETAL STIFFNESS (Felt like crook in the neck) and INJECTION SITE PAIN (pain from injection site towards up to the neck,When she would touch the injection site and it was still sore). The patient was treated with IBUPROFEN for Adverse event, at a dose of UNK dosage form. At the time of the report, NECK PAIN (pain from injection site towards up to the neck), HYPERSENSITIVITY (bad irritation), EAR PAIN (Ear was aching), MUSCULOSKELETAL STIFFNESS (Felt like crook in the neck) and INJECTION SITE PAIN (pain from injection site towards up to the neck,When she would touch the injection site and it was still sore) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  It was reported that, patient had a bad irritation and had to put a heat pad on it. The patient was concerned that the pain lasted a few weeks. The patient visited the doctor and the doctor did not find anything.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Nausea
Clinical narrative: body aches; headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (body aches), HEADACHE (headache) and NAUSEA (nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Mar-2021, the patient experienced MYALGIA (body aches), HEADACHE (headache) and NAUSEA (nausea). At the time of the report, MYALGIA (body aches), HEADACHE (headache) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information not provided.  Treatment information not provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Dizziness, Headache, Mass, Pruritus
Clinical narrative: arm became itchy; arm had a lump; dizziness; joint pain,a lot of joint pain.; redness around the injection site is large as a 1 dollar bill; head ache,such a bad head ache; sore at the injection site; a low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (arm became itchy), MASS (arm had a lump), DIZZINESS (dizziness), PYREXIA (a low grade fever) and ARTHRALGIA (joint pain,a lot of joint pain.) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder. Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] and ATORVASTATIN CALCIUM, EZETIMIBE (STATIN EZ) for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PYREXIA (a low grade fever). On an unknown date, the patient experienced PRURITUS (arm became itchy), MASS (arm had a lump), DIZZINESS (dizziness), ARTHRALGIA (joint pain,a lot of joint pain.), VACCINATION SITE ERYTHEMA (redness around the injection site is large as a 1 dollar bill), HEADACHE (head ache,such a bad head ache) and VACCINATION SITE PAIN (sore at the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form. At the time of the report, PRURITUS (arm became itchy), MASS (arm had a lump), DIZZINESS (dizziness), PYREXIA (a low grade fever), ARTHRALGIA (joint pain,a lot of joint pain.), VACCINATION SITE ERYTHEMA (redness around the injection site is large as a 1 dollar bill), HEADACHE (head ache,such a bad head ache) and VACCINATION SITE PAIN (sore at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The additional concomitant drugs included thyroid medication.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site pain
Clinical narrative: arm became itchy; arm had a lump; dizziness; joint pain,a lot of joint pain.; redness around the injection site is large as a 1 dollar bill; head ache,such a bad head ache; sore at the injection site; a low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (arm became itchy), MASS (arm had a lump), DIZZINESS (dizziness), PYREXIA (a low grade fever) and ARTHRALGIA (joint pain,a lot of joint pain.) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 immunisation. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Thyroid disorder. Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] and ATORVASTATIN CALCIUM, EZETIMIBE (STATIN EZ) for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced PYREXIA (a low grade fever). On an unknown date, the patient experienced PRURITUS (arm became itchy), MASS (arm had a lump), DIZZINESS (dizziness), ARTHRALGIA (joint pain,a lot of joint pain.), VACCINATION SITE ERYTHEMA (redness around the injection site is large as a 1 dollar bill), HEADACHE (head ache,such a bad head ache) and VACCINATION SITE PAIN (sore at the injection site). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form. At the time of the report, PRURITUS (arm became itchy), MASS (arm had a lump), DIZZINESS (dizziness), PYREXIA (a low grade fever), ARTHRALGIA (joint pain,a lot of joint pain.), VACCINATION SITE ERYTHEMA (redness around the injection site is large as a 1 dollar bill), HEADACHE (head ache,such a bad head ache) and VACCINATION SITE PAIN (sore at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The additional concomitant drugs included thyroid medication.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: itchiness; Rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchiness) and RASH (Rash) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PRURITUS (itchiness) and RASH (Rash). At the time of the report, PRURITUS (itchiness) and RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  The patient reported scratching at the itchy rash. No treatment was reported for the events.   On 04-May-2021 the patient endorsed feeling much better.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Initial additional
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia
Clinical narrative: muscle pain; joint pain; headache; tired; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (muscle pain), ARTHRALGIA (joint pain), HEADACHE (headache) and FATIGUE (tired) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 immunisation.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced MYALGIA (muscle pain), ARTHRALGIA (joint pain), HEADACHE (headache) and FATIGUE (tired). In February 2021, MYALGIA (muscle pain), ARTHRALGIA (joint pain), HEADACHE (headache) and FATIGUE (tired) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No Concomitant  medications were reported. No Treatments were reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia, Vaccination site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: red spot at the injection site (4inch diameter); Fever of 100.4F; Sore at the injection site/ Painfull at injection site; injection site is warm to the touch; swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (injection site is warm to the touch), VACCINATION SITE SWELLING (swelling), VACCINATION SITE PAIN (Sore at the injection site/ Painfull at injection site), VACCINATION SITE ERYTHEMA (red spot at the injection site (4inch diameter)) and PYREXIA (Fever of 100.4F) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 207030m20A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: FLU. Concurrent medical conditions included Egg allergy (Raw eggs), Penicillin allergy, Sulfonamide allergy (Allergic to sulfa drugs.), Drug allergy (lopresser), Asthma since 1956, Hypothyroidism since 1969, Pre-diabetic since 2000, Acid reflux (oesophageal) since 2010 and Hypophosphatasia since 1985. Concomitant products included METFORMIN, LEVOTHYROXINE SODIUM (SYNTHROID), LOSARTAN POTASSIUM, AMLODIPINE, AMITRIPTYLINE HCL and OMEPRAZOLE for an unknown indication.    On 19-Feb-2021 at 3:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION SITE WARMTH (injection site is warm to the touch) and VACCINATION SITE SWELLING (swelling). On 20-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore at the injection site/ Painfull at injection site). On 21-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (red spot at the injection site (4inch diameter)) and PYREXIA (Fever of 100.4F). The patient was treated with PARACETAMOL (TYLENOL) for Vaccination site swelling, Vaccination site warmth and Vaccination site pain, at a dose of Hour after injection and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) 19-Mar-2021 for Swelling, at a dose of 1/2 hour before/1hour after. On 23-Feb-2021, PYREXIA (Fever of 100.4F) had resolved. On 10-Mar-2021, VACCINATION SITE WARMTH (injection site is warm to the touch), VACCINATION SITE SWELLING (swelling), VACCINATION SITE PAIN (Sore at the injection site/ Painfull at injection site) and VACCINATION SITE ERYTHEMA (red spot at the injection site (4inch diameter)) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Feb-2021, Body temperature: 100.4 f (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: no new information was added. On 13-Jul-2021: AE outcome and other medical history has been provided. Treatment medication was updated.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: red spot at the injection site (4inch diameter); Fever of 100.4F; Sore at the injection site/ Painfull at injection site; injection site is warm to the touch; swelling; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (injection site is warm to the touch), VACCINATION SITE SWELLING (swelling), VACCINATION SITE PAIN (Sore at the injection site/ Painfull at injection site), VACCINATION SITE ERYTHEMA (red spot at the injection site (4inch diameter)) and PYREXIA (Fever of 100.4F) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 207030m20A) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: FLU. Concurrent medical conditions included Egg allergy (Raw eggs), Penicillin allergy, Sulfonamide allergy (Allergic to sulfa drugs.), Drug allergy (lopresser), Asthma since 1956, Hypothyroidism since 1969, Pre-diabetic since 2000, Acid reflux (oesophageal) since 2010 and Hypophosphatasia since 1985. Concomitant products included METFORMIN, LEVOTHYROXINE SODIUM (SYNTHROID), LOSARTAN POTASSIUM, AMLODIPINE, AMITRIPTYLINE HCL and OMEPRAZOLE for an unknown indication.    On 19-Feb-2021 at 3:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, the patient experienced VACCINATION SITE WARMTH (injection site is warm to the touch) and VACCINATION SITE SWELLING (swelling). On 20-Feb-2021, the patient experienced VACCINATION SITE PAIN (Sore at the injection site/ Painfull at injection site). On 21-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (red spot at the injection site (4inch diameter)) and PYREXIA (Fever of 100.4F). The patient was treated with PARACETAMOL (TYLENOL) for Vaccination site swelling, Vaccination site warmth and Vaccination site pain, at a dose of Hour after injection and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (oral) 19-Mar-2021 for Swelling, at a dose of 1/2 hour before/1hour after. On 23-Feb-2021, PYREXIA (Fever of 100.4F) had resolved. On 10-Mar-2021, VACCINATION SITE WARMTH (injection site is warm to the touch), VACCINATION SITE SWELLING (swelling), VACCINATION SITE PAIN (Sore at the injection site/ Painfull at injection site) and VACCINATION SITE ERYTHEMA (red spot at the injection site (4inch diameter)) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Feb-2021, Body temperature: 100.4 f (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: no new information was added. On 13-Jul-2021: AE outcome and other medical history has been provided. Treatment medication was updated.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: Hot below injection site; Itching below injection site; Redness below injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot below injection site), VACCINATION SITE PRURITUS (Itching below injection site) and VACCINATION SITE ERYTHEMA (Redness below injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history provided.).    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced VACCINATION SITE WARMTH (Hot below injection site), VACCINATION SITE PRURITUS (Itching below injection site) and VACCINATION SITE ERYTHEMA (Redness below injection site). The patient was treated with PARACETAMOL (TYLENOL) (oral) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE WARMTH (Hot below injection site), VACCINATION SITE PRURITUS (Itching below injection site) and VACCINATION SITE ERYTHEMA (Redness below injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided. Treatment for the events included Tylenol.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Initial additional
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Therapeutic response unexpected
Clinical narrative: Sore arm; After receiving the vaccine started experiencing a relief for the arthritis. Now lost the pain in the joints; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and THERAPEUTIC RESPONSE UNEXPECTED (After receiving the vaccine started experiencing a relief for the arthritis. Now lost the pain in the joints) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     The patient's past medical history included Breast cancer (breast cancer survivor.). Concurrent medical conditions included Arthritis.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and THERAPEUTIC RESPONSE UNEXPECTED (After receiving the vaccine started experiencing a relief for the arthritis. Now lost the pain in the joints). At the time of the report, PAIN IN EXTREMITY (Sore arm) had resolved and THERAPEUTIC RESPONSE UNEXPECTED (After receiving the vaccine started experiencing a relief for the arthritis. Now lost the pain in the joints) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant Description included Arthritis treatment.  No Treatments were reported
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia, Vaccination site pain
Clinical narrative: Headache; Sore arm at injection site; Body ache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEADACHE (Headache), VACCINATION SITE PAIN (Sore arm at injection site) and MYALGIA (Body ache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Headache), VACCINATION SITE PAIN (Sore arm at injection site) and MYALGIA (Body ache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of UNK dosage form. At the time of the report, HEADACHE (Headache) had not resolved and VACCINATION SITE PAIN (Sore arm at injection site) and MYALGIA (Body ache) had resolved.            Concomitant medications was not provided by the reporter.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache  for 3 days; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (Headache  for 3 days) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.  Concomitant products included ORAL CONTRACEPTIVE NOS and LISINOPRIL for an unknown indication.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced HEADACHE (Headache  for 3 days). At the time of the report, HEADACHE (Headache  for 3 days) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No corrective treatment was provided.
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Pain in extremity
Clinical narrative: slight arm pain; injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (slight arm pain) and INJECTION SITE PAIN (injection site pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (slight arm pain) and INJECTION SITE PAIN (injection site pain). At the time of the report, PAIN IN EXTREMITY (slight arm pain) and INJECTION SITE PAIN (injection site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitants medications were reported. No Treatments were reported.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Headache, Myalgia
Clinical narrative: not feeling good today and feels "beat up; headache; feeling "achy"; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (not feeling good today and feels "beat up), HEADACHE (headache) and MYALGIA (feeling "achy") in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 013M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Mar-2021, the patient experienced FEELING ABNORMAL (not feeling good today and feels "beat up), HEADACHE (headache) and MYALGIA (feeling "achy"). At the time of the report, FEELING ABNORMAL (not feeling good today and feels "beat up), HEADACHE (headache) and MYALGIA (feeling "achy") outcome was unknown. Not Provided          No Concomitants were provided.  No treatment medications reported.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine, Chest discomfort, Erythema, Migraine, Pain in extremity
Clinical narrative: might be an allergic reaction; chest is tight; hives; very achy legs; migraine; very red cheeks; high fever; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY (very achy legs), MIGRAINE (migraine), URTICARIA (hives), CHEST DISCOMFORT (chest is tight) and ALLERGY TO VACCINE (might be an allergic reaction) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety.   On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced PAIN IN EXTREMITY (very achy legs), MIGRAINE (migraine), ERYTHEMA (very red cheeks) and PYREXIA (high fever). On 10-Mar-2021, the patient experienced URTICARIA (hives). On 11-Mar-2021, the patient experienced CHEST DISCOMFORT (chest is tight). On an unknown date, the patient experienced ALLERGY TO VACCINE (might be an allergic reaction). The patient was treated with PREDNISONE at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (very achy legs), MIGRAINE (migraine), URTICARIA (hives), CHEST DISCOMFORT (chest is tight), ALLERGY TO VACCINE (might be an allergic reaction), ERYTHEMA (very red cheeks) and PYREXIA (high fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication included an unspecified anti-anxiety medication.   This case was linked to MOD-2021-219972 (Patient Link).
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Urticaria
Clinical narrative: might be an allergic reaction; chest is tight; hives; very achy legs; migraine; very red cheeks; high fever; This spontaneous case was reported by a health care professional and describes the occurrence of PAIN IN EXTREMITY (very achy legs), MIGRAINE (migraine), URTICARIA (hives), CHEST DISCOMFORT (chest is tight) and ALLERGY TO VACCINE (might be an allergic reaction) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Anxiety.   On 05-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, the patient experienced PAIN IN EXTREMITY (very achy legs), MIGRAINE (migraine), ERYTHEMA (very red cheeks) and PYREXIA (high fever). On 10-Mar-2021, the patient experienced URTICARIA (hives). On 11-Mar-2021, the patient experienced CHEST DISCOMFORT (chest is tight). On an unknown date, the patient experienced ALLERGY TO VACCINE (might be an allergic reaction). The patient was treated with PREDNISONE at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (very achy legs), MIGRAINE (migraine), URTICARIA (hives), CHEST DISCOMFORT (chest is tight), ALLERGY TO VACCINE (might be an allergic reaction), ERYTHEMA (very red cheeks) and PYREXIA (high fever) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication included an unspecified anti-anxiety medication.   This case was linked to MOD-2021-219972 (Patient Link).
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaginal haemorrhage
Clinical narrative: vaginal bloody discharge; arm was little sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm was little sore) and VAGINAL HAEMORRHAGE (vaginal bloody discharge) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (arm was little sore). On 10-Mar-2021, the patient experienced VAGINAL HAEMORRHAGE (vaginal bloody discharge). On 10-Mar-2021, PAIN IN EXTREMITY (arm was little sore) had resolved. At the time of the report, VAGINAL HAEMORRHAGE (vaginal bloody discharge) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Other relevant medication history included high blood pressure medicine.  Patient was using a heating pad . Treatment information was not provided.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Pain in extremity
Clinical narrative: Fell; Hurt their leg; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FALL (Fell) and PAIN IN EXTREMITY (Hurt their leg) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, the patient experienced FALL (Fell) and PAIN IN EXTREMITY (Hurt their leg). The patient was treated with PREDNISONE for Adverse event, at a dose of 10 mg and DOXEPIN HYDROCHLORIDE (ADAPIN) for Adverse event, at a dose of 800 mg. At the time of the report, FALL (Fell) and PAIN IN EXTREMITY (Hurt their leg) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.  Patient fell and hurt the leg. Doctor advised him not to drive very far.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Palpitations, Pruritus
Clinical narrative: Palpitations; Sore arm; Flaming red; Her arm was flaming red and itchy; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Palpitations), PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Flaming red) and PRURITUS (Her arm was flaming red and itchy) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001a21a) for COVID-19 vaccination.     Concurrent medical conditions included Anxiety (she has an extra heart beat with anxiety).    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PALPITATIONS (Palpitations), PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Flaming red) and PRURITUS (Her arm was flaming red and itchy). On 13-Mar-2021, PAIN IN EXTREMITY (Sore arm), ERYTHEMA (Flaming red) and PRURITUS (Her arm was flaming red and itchy) had resolved. At the time of the report, PALPITATIONS (Palpitations) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-May-2021: Initial additional, two new events and outcome added. On 23-Jul-2021: Outcome updated and end date removed for the event of palpitations.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Limb discomfort, Peripheral swelling, Pyrexia, Vaccination site pain
Clinical narrative: heavyness and swelling of the arm; heavyness and swelling of the arm; Soreness of left arm; chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (heavyness and swelling of the arm), LIMB DISCOMFORT (heavyness and swelling of the arm), VACCINATION SITE PAIN (Soreness of left arm), CHILLS (chills) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, the patient experienced PERIPHERAL SWELLING (heavyness and swelling of the arm), LIMB DISCOMFORT (heavyness and swelling of the arm), VACCINATION SITE PAIN (Soreness of left arm), CHILLS (chills) and PYREXIA (Fever). The patient was treated with PARACETAMOL (TYLENOL) (oral) at a dose of 1 dosage form. At the time of the report, PERIPHERAL SWELLING (heavyness and swelling of the arm), LIMB DISCOMFORT (heavyness and swelling of the arm), VACCINATION SITE PAIN (Soreness of left arm), CHILLS (chills) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided by reporter.   Reporter did not allow further contact
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Nausea; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Nausea) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 04-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced NAUSEA (Nausea). At the time of the report, NAUSEA (Nausea) outcome was unknown. Not Provided          No Concomitant information  provided. No Treatment information  provided
Age: 46.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 antibody test negative
Clinical narrative: tested negative for antibodies; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 ANTIBODY TEST NEGATIVE (tested negative for antibodies) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced SARS-COV-2 ANTIBODY TEST NEGATIVE (tested negative for antibodies). At the time of the report, SARS-COV-2 ANTIBODY TEST NEGATIVE (tested negative for antibodies) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant information  provided. No Treatment information  provided
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymphadenopathy, Oral herpes, Pain, Vaccination site swelling
Clinical narrative: Cold sore; Swelling of the lymph nodes underneath her arm; Swelling at the injection site; Headache; Achiness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 11-Mar-2021 and was forwarded to Moderna on 11-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Achiness), ORAL HERPES (Cold sore), LYMPHADENOPATHY (Swelling of the lymph nodes underneath her arm), VACCINATION SITE SWELLING (Swelling at the injection site) and HEADACHE (Headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported. ). Concomitant products included LISINOPRIL for an unknown indication.    On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Feb-2021, the patient experienced PAIN (Achiness), LYMPHADENOPATHY (Swelling of the lymph nodes underneath her arm), VACCINATION SITE SWELLING (Swelling at the injection site) and HEADACHE (Headache). On an unknown date, the patient experienced ORAL HERPES (Cold sore). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (Achiness), ORAL HERPES (Cold sore), LYMPHADENOPATHY (Swelling of the lymph nodes underneath her arm), VACCINATION SITE SWELLING (Swelling at the injection site) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Influenza like illness, Myalgia, Pain in extremity, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arm), RHINORRHOEA (Running nose), INFLUENZA LIKE ILLNESS (Flulike symptoms), MYALGIA (Muscle pain) and CHILLS (Chills) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Artificial cardiac pacemaker user and Immune disorder (NOS). Concomitant products included ESCITALOPRAM and AMITRIPTYLINE for an unknown indication. On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in arm), RHINORRHOEA (Running nose), INFLUENZA LIKE ILLNESS (Flulike symptoms), MYALGIA (Muscle pain), CHILLS (Chills) and PYREXIA (temperature of 102). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (pain in arm), RHINORRHOEA (Running nose), INFLUENZA LIKE ILLNESS (Flulike symptoms), MYALGIA (Muscle pain), CHILLS (Chills) and PYREXIA (temperature of 102) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment included Tylenol This case was linked to MOD-2021-041081 (E2B Linked Report).; Sender's Comments:  MOD-2021-041081:
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arm), RHINORRHOEA (Running nose), INFLUENZA LIKE ILLNESS (Flulike symptoms), MYALGIA (Muscle pain) and CHILLS (Chills) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Artificial cardiac pacemaker user and Immune disorder (NOS). Concomitant products included ESCITALOPRAM and AMITRIPTYLINE for an unknown indication. On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in arm), RHINORRHOEA (Running nose), INFLUENZA LIKE ILLNESS (Flulike symptoms), MYALGIA (Muscle pain), CHILLS (Chills) and PYREXIA (temperature of 102). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (pain in arm), RHINORRHOEA (Running nose), INFLUENZA LIKE ILLNESS (Flulike symptoms), MYALGIA (Muscle pain), CHILLS (Chills) and PYREXIA (temperature of 102) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment included Tylenol This case was linked to MOD-2021-041081 (E2B Linked Report).; Sender's Comments:  MOD-2021-041081:
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Lymph node pain, Lymphadenopathy
Clinical narrative: was unaware that I was pregnant when I received the first dose (I was only about 2 weeks pregnant); Swollen lymph node above collar bone on the left side, which also tender; Once swollen lymph node above collar bone on left side; This spontaneous pregnancy case was reported by a consumer and describes the occurrence of LYMPH NODE PAIN (Swollen lymph node above collar bone on the left side, which also tender), EXPOSURE DURING PREGNANCY (was unaware that I was pregnant when I received the first dose (I was only about 2 weeks pregnant)) and LYMPHADENOPATHY (Once swollen lymph node above collar bone on left side) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No medical history was reported.  Concurrent medical conditions included Asthma in 1981, Depression in 2008, Anxiety in 2008, Allergy to nuts and Drug allergy. Concomitant products included SALBUTAMOL (ALBUTEROL HFA) for Asthma, FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) and ESCITALOPRAM OXALATE (LEXAPRO) for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 19-Nov-2021. On 11-Mar-2021, the patient experienced LYMPH NODE PAIN (Swollen lymph node above collar bone on the left side, which also tender) and LYMPHADENOPATHY (Once swollen lymph node above collar bone on left side). On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (was unaware that I was pregnant when I received the first dose (I was only about 2 weeks pregnant)). At the time of the report, LYMPH NODE PAIN (Swollen lymph node above collar bone on the left side, which also tender), EXPOSURE DURING PREGNANCY (was unaware that I was pregnant when I received the first dose (I was only about 2 weeks pregnant)) and LYMPHADENOPATHY (Once swollen lymph node above collar bone on left side) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Antibiotics and Steroids   This case was linked to MOD-2021-234755 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Significant follow up appended.